🎯 #TASLC25 International Symposium
🎖️Chair: Prof. James Yang
🌟Faculties: Drs. David Gandara, Fred Hirsch, @solangepeters.bsky.social @bensolomon1.bsky.social Tony Mok, Daniel Tan, Justin Gainor, Martin Reck, Karen Kelly, and more
@oncoalert.bsky.social
🎯 #TASLC25 International Symposium
🎖️Chair: Prof. James Yang
🌟Faculties: Drs. David Gandara, Fred Hirsch, @solangepeters.bsky.social @bensolomon1.bsky.social Tony Mok, Daniel Tan, Justin Gainor, Martin Reck, Karen Kelly, and more
@oncoalert.bsky.social
✅Controversies in Thoracic Oncology
🎯Adj ICI in pCR by Neo-ICI
🆗Adj ICI🆗
🗣️Dr. Dipesh Uprety @solangepeters.bsky.social
jto.org/article/S155...
◀️🆚▶️
🆖Adj ICI🆖
🗣️Dr. William Phillips @drcamidge.bsky.social
jto.org/article/S155...
#LCSM @oncoalert.bsky.social
✅Controversies in Thoracic Oncology
🎯Adj ICI in pCR by Neo-ICI
🆗Adj ICI🆗
🗣️Dr. Dipesh Uprety @solangepeters.bsky.social
jto.org/article/S155...
◀️🆚▶️
🆖Adj ICI🆖
🗣️Dr. William Phillips @drcamidge.bsky.social
jto.org/article/S155...
#LCSM @oncoalert.bsky.social
#BTOG25
#BTOG25
🙌find strength in your team
🙌defend what is right
🙌you can do ANYTHING but not everything
🙌fight imposter syndrome - you deserve to be there
youtu.be/i6fe2EK2lh8?...
@solangepeters.bsky.social
@drjnaidoo.bsky.social
#ESMO #Women4Oncology #oncology
🙌find strength in your team
🙌defend what is right
🙌you can do ANYTHING but not everything
🙌fight imposter syndrome - you deserve to be there
youtu.be/i6fe2EK2lh8?...
@solangepeters.bsky.social
@drjnaidoo.bsky.social
#ESMO #Women4Oncology #oncology
A snapshot of members & the important themes fostered this year: community, leadership, support 🌍
Watch this space for new creative content & events in 2025 🏆 @elinardou.bsky.social @solangepeters.bsky.social
A snapshot of members & the important themes fostered this year: community, leadership, support 🌍
Watch this space for new creative content & events in 2025 🏆 @elinardou.bsky.social @solangepeters.bsky.social
Proffered paper🔥
Ph III CM73L: Nivo+cCRT➡️consol Nivo/Ipi v Nivo v cCRT➡️Durva @solangepeters.bsky.social
- no PFS/OS benefit
- g3+TRAE 57%, 54%, 49%
- concerning pneumonitis signal
Concurrent RT+IO - going going gone
@oncoalert.bsky.social #LCSM #Medsky #Oncsky
Proffered paper🔥
Ph III CM73L: Nivo+cCRT➡️consol Nivo/Ipi v Nivo v cCRT➡️Durva @solangepeters.bsky.social
- no PFS/OS benefit
- g3+TRAE 57%, 54%, 49%
- concerning pneumonitis signal
Concurrent RT+IO - going going gone
@oncoalert.bsky.social #LCSM #Medsky #Oncsky